Edition:
United States

Prophase Labs Inc (PRPH.OQ)

PRPH.OQ on NASDAQ Stock Exchange Capital Market

2.27USD
22 Sep 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.27
Open
$2.28
Day's High
$2.28
Day's Low
$2.28
Volume
54
Avg. Vol
4,505
52-wk High
$2.37
52-wk Low
$1.78

Chart for

About

ProPhase Labs, Inc. manufactures, markets and distributes a range of homeopathic and healthcare products. The Company is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The Company's products include TK... (more)
No analyst recommendations are available for .

Overall

Beta: 0.03
Market Cap(Mil.): $36.70
Shares Outstanding(Mil.): 16.17
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 22.75 15.95
EPS (TTM): -- -- --
ROI: -- 12.41 15.19
ROE: -- 15.81 13.87

BRIEF-ProPhase Labs CFO Robert Cuddihy to resign

* Says ‍on August 22, CFO Robert V. Cuddihy Jr., notified company of his intention to resign - SEC filing​

Aug 24 2017

BRIEF-Prophase Labs Inc qtrly sales $1.9 million

* Prophase Labs reports financial results for the three months and six months ended June 30, 2017

Aug 11 2017

BRIEF-ProPhase provides shareholder update

* ProPhase Labs Inc- Company received net proceeds from sale of cold-eeze(®) of approximately $39.3 million after certain deductions

Apr 05 2017

Earnings vs. Estimates

No consensus analysis data available.